Sawai Sets Upsher-Smith $50m+ Target For Former Reddy’s Brands
• By Aidan Fry
Sawai Believes Its Upsher-Smith Unit In The US Could More than Double Annual Sales Of Two Sumatriptan Brands Acquired For Dr Reddy's To More Than $50m • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
